EdgarLookup

GSK plc

Insider transactions at 2 companies

This page shows all SEC Form 4 filings attributed to GSK plc. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

WVE TBPH
Company Title Type Shares Price Value Date
WVE Purchase 1,470,000 $19.00 $27,930,000 Dec 11, 2025
WVE Purchase 2,791,930 $8.00 $22,335,440 Sep 27, 2024
WVE Purchase 3,300,000 $5.00 $16,500,000 Dec 7, 2023
TBPH Other 9,644,807 $9.75 $94,036,868 Sep 16, 2022